ProShare Advisors’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $194K | Sell |
|
|||||
|
2025
Q1 | $191K | Sell |
|
|||||
|
2024
Q4 | $322K | Buy |
|
|||||
|
2024
Q3 | $304K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $122K | Buy |
|
|||||
|
2021
Q2 | $71K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $75K | Sell |
|
|||||
|
2018
Q2 | $108K | Sell |
|
|||||
|
2018
Q1 | $139K | Sell |
|
|||||
|
2017
Q4 | $182K | Sell |
|
|||||
|
2017
Q3 | $240K | Buy |
|
|||||
|
2017
Q2 | $229K | Sell |
|
|||||
|
2017
Q1 | $209K | Sell |
|
|||||
|
2016
Q4 | $277K | Buy |
|
|||||
|
2016
Q3 | $315K | Sell |
|
|||||
|
2016
Q2 | $322K | Buy |
|
|||||
|
2016
Q1 | $329K | Sell |
|
|||||
|
2015
Q4 | $395K | Buy |
|
|||||
|
2015
Q3 | $492K | Sell |
|
|||||
|
2015
Q2 | $665K | Sell |
|
|||||
|
2015
Q1 | $565K | Buy |
|
|||||
|
2014
Q4 | $430K | Buy |
|